Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 060125/0300 | |
| Pages: | 5 |
| | Recorded: | 06/07/2022 | | |
| Attorney Dkt #: | BCLS-000 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
4
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/20/2022
|
Application #:
|
16486481
|
Filing Dt:
|
10/22/2019
|
|
Publication #:
|
|
Pub Dt:
|
11/28/2019
| | | | |
|
Title:
|
ANTIBODY TARGETING IL-13RA2 AND USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/23/2022
|
Application #:
|
16618047
|
Filing Dt:
|
11/27/2019
|
|
Publication #:
|
|
Pub Dt:
|
05/07/2020
| | | | |
|
Title:
|
COMPOSITIONS AND METHODS OF CELLULAR IMMUNOTHERAPY
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16966789
|
Filing Dt:
|
10/02/2020
|
|
Publication #:
|
|
Pub Dt:
|
04/22/2021
| | | | |
|
Title:
|
COMBINATION OF CELLULAR IMMUNOTHERAPY
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17277142
|
Filing Dt:
|
12/15/2021
|
|
Publication #:
|
|
Pub Dt:
|
03/31/2022
| | | | |
|
Title:
|
CHEMOKINE EXPRESSING CELL AND USE THEREOF
|
|
|
Assignee
|
|
|
|
|
| RM12, 20/F, HO KING COMM CTR |
| 2-16 FAYUEN ST |
| MONGKOK KOWLOON, HONG KONG |
|
|
Correspondence name and address
|
| |
NELSON MULLINS RILEY & SCARBOROUGH LLP
|
| |
ONE FINANCIAL CENTER
|
| |
SUITE 3500
|
| |
BOSTON, MA 02111
|
Search Results as of:
09/26/2024 04:53 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
